Clinical evaluation of the Tina-quant % CDT 2nd gen. test.

被引：0
|
作者：
Hock, B
Schwarz, M
Domke, I
Wuertemberger, M
Soyka, M
机构：
[1] Univ Munich, Psychiat Klin, D-80336 Munich, Germany
[2] Roche Diagnost GmbH, D-68305 Mannheim, Germany
来源：
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | 2004年 / 28卷 / 08期
关键词：
D O I：
10.1097/00000374-200408002-00161
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页码：33A / 33A
页数：1
相关论文
共 45 条
  • [1] Clinical evaluation of the Tina-quant % CDT test on Roche/Hitachi 912.
    Domke, I
    Hock, B
    Schwarz, MJ
    Wuertemberger, M
    Ackenheil, M
    Soyka, M
    CLINICAL CHEMISTRY, 2004, 50 (06) : A147 - A148
  • [2] Multicenter evaluation of Tina-quant® D-dimer Gen. 2, a reagent optimized with respect to Precision and Interference
    Hubbuch, A. P.
    Grawitz, A. Busse
    Mueller, M.
    Honauer, G.
    Maier, H.
    Stein, C.
    CLINICAL CHEMISTRY, 2009, 55 (06) : A39 - A39
  • [3] Evaluation of the technical feasibility of Tina-quant® [a] HbA1c Gen. 2 assay on COBAS INTEGRA® 800
    Miedema, K
    Lenters-Westra, E
    Horowitz, G
    Pistorino, A
    Patel, R
    Ng, K
    Wuertemberger, M
    Roeddiger, R
    CLINICAL CHEMISTRY, 2005, 51 : A234 - A234
  • [4] Evaluation of the technical feasibility of TINA-QUANT® [a] HbA1c Gen.2 assay on cobas INTEGRA® 800
    Miedema, K
    Lenters, E
    Würtemberger, M
    Röddiger, R
    CLINICA CHIMICA ACTA, 2005, 355 : S335 - S335
  • [5] Cobas Integra Tina-Quant Hemoglobin A1c Gen.2 Assay: Accurate and precise with no interference from Hb variants
    Luzzi, V. I.
    McKenna, M.
    Landry, C.
    Karsteter, L.
    Mongia, S. K.
    Roberts, W. L.
    Rohlfing, C. L.
    Tennill, A.
    Little, R. R.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A231 - A231
  • [6] Deep vein thrombosis and pulmonary embolism: a prospective, observational study to evaluate diagnostic performance of the Tina-quant D-Dimer Gen.2 assay
    Bertsch, Thomas
    Behringer, Wilhelm
    Blaschke, Sabine
    Body, Richard
    Davidson, Simon
    Mueller-Olling, Mirco
    Guo, Ge
    Rieger, Anna
    Wahl, Annika
    Horner, Daniel
    Sun, Yuli
    Turnes, Lucia
    Sonner, Ulrich
    Hoffmann, Michael
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [7] Diagnostic Accuracy of the Tina-Quant D-Dimer Gen.2 Assay with Age-Adjusted Cut-Off Ranges for Evaluation of Patients with Suspected Deep Vein Thrombosis or Pulmonary Embolism
    Bertsch, Thomas
    Behringer, Wilhelm
    Blaschke, Sabine
    Body, Richard
    Davidson, Simon
    Rieger, Anna
    Horner, Daniel
    Sonner, Ulrich
    Sun, Yuli
    Turnes, Lucia
    Hoffman, Michael
    BLOOD, 2020, 136
  • [8] Blue Biofuels, GMP design new 2nd gen. biofuel plant
    不详
    SUGAR INDUSTRY INTERNATIONAL, 2025, 150 (01): : 34 - 34
  • [9] Verbio buys 2nd gen. ethanol plant in Iowa, plans biogas expansion
    不详
    SUGAR INDUSTRY-ZUCKERINDUSTRIE, 2018, 143 (12): : 690 - 690
  • [10] In vivo statin study shows no drug interference with the new Roche diagnistics HDL-C plus 3rd generation HDL-C plus 2nd generation, LDL-C plus 2nd generation, or the Tina-quant® high sensitive CRP assays
    Ryan, M. J.
    Berger, S.
    Marcovina, S.
    Bruton, D. T.
    Foster, A.
    Rose, A.
    Domke, I.
    Klima, H.
    CLINICAL CHEMISTRY, 2006, 52 (06) : A111 - A112
12345